Report Code: 10657 | Available Format: PDF | Pages: 288
The global enteral nutrition market size was valued at $8,037.55 million in 2021, and it is projected to reach $13,811.6 million by 2030, growing at a CAGR of 6.2% during 2021–2030. This growth can be attributed to the growing geriatric population, surging number of victims of malnutrition receiving treatment, and lower cost of products.
This is the most preferred way of feeding infants who are vulnerable to disease and death, due to undernutrition and deficiencies in vitamins and minerals. Furthermore, an increase in awareness about the advantages of early enteral feeding, which reduces septic and non-septic complications and improves clinical outcomes of critically ill and injured patients, is expected to boost the market growth over the years.
Moreover, shifting preference from parenteral nutrition to enteral is another major factor driving the market, as it is gaining popularity over the years, owing to the improvement in techniques, compositions, and materials. Parenteral is a less preferred technique due to its higher complication rate and cost. However, parenteral nutrition is preferred only when patients are unable to tolerate enteral procedures. This has shifted the interest of players providing clinical nutrition from parenteral nutrition to enteral, which is also is being preferred for long-term feeding in old age patients, thereby fuelling the product demand in the market.
The standard enteral nutrition category held the largest revenue share in 2021. This is primarily driven by the widespread acceptance of regular protein diets, since it is one of the most preferred compositions suggested for patients suffering from diabetes, cancer, and other disorders that make it difficult to consume solid meals. The introduction of typical protein-rich products is meeting the market demand. Furthermore, there has been a significant increase in the need for products derived from organic sources, resulting in the rising demand for conventional protein diets.
Protein nutrients held a larger market share, in 2021, due to the increasing consumer awareness regarding balanced diets across the world. The increased demand for protein nutrients is driven by socio-economic changes such as rising disposable income, the aging population, and the recognition of the role of protein in a healthy diet.
Furthermore, economic development and rapid urbanization are leading to major transitions in population-level dietary patterns in emerging countries in particular, such that most of the increased demand for foods of animal origin is seen in developing nations.
Report Attribute | Details |
Historical Years |
2017-2021 |
Forecast Years |
2022-2030 |
Market Size in 2021 |
$8,037.55 Million |
Revenue Forecast in 2030 |
$13,811.6 Million |
Growth Rate |
6.2% CAGR |
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Segmentation Analysis of Countries; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
Segments Covered |
By Product Type; By Nutrition Type; By Form; By Patient Type; By Distribution Channel; By Region |
Explore more about this report - Request free sample
The hospital pharmacies category accounted for the highest revenue share, of more than 60%, in 2021, and it is expected to dominate the market in the coming years as well. This is due to the increased number of inpatients and outpatients in hospitals, as well as patients' preference for hospital pharmacies.
The prices of pharmaceuticals in hospital pharmacies are lower as compared to other distribution channels, and customers are free to negotiate with hospital officials based on their budget. Also, easy access to these pharmacies is a major driver to boosting the sales of pharmaceutical products, thereby driving the growth of the market.
Whereas, the online pharmacies category is projected to witness the highest CAGR during the forecast period. This can be because the enhanced patient-provider communication and promotional campaigns are projected to increase the online delivery of enteral feeding products for short- and long-term care among critical patients. Also, it provides comfort to patients with the delivery of essentials to their place of stay.
The liquid form category held around more than 70% market share in 2021, and it is expected to grow at a substantial CAGR during the forecast period. The liquid form of these products is a ready-to-use or instant nutrition formula available in prefilled, ready-to-hang containers and specially designed cans for tube feeding. Before being boosted or pierced with a feeding set, these packages can be kept at room temperature. The rapid absorption of the formula by the gastric walls, resulting in a quicker metabolic rate, is one of the significant benefits of taking these products in a liquid form.
Adult patients category is predicted to grow at a significant pace in the coming years. Furthermore, patients with a body mass index of <20 are considered chronically ill and typically suffer from cancer, gastrointestinal diseases, respiratory issues, and neurological or psychiatric disorders. These patients are at high risk for malnutrition, and such factor stimulates the growth of the market in this category.
North America held the largest revenue share, of more than 33%, in 2021 in the market. This is due to the well-established healthcare industry and the presence of a large number of product manufacturers in the region. Moreover, the increased use of nutritional products and the rise in the number of patients with chronic diseases have boosted the demand for nutrition products in North America.
Furthermore, an increase in the number of patients suffering from gastrointestinal disorders in the U.S. drives the adoption of tube nutrition. For instance, according to the Office of Disease Prevention and Health Promotion report, chronic diseases are the leading cause of death in the U.S., i.e., 7 out of 10 deaths per year.
In addition, Europe accounts for the second-largest share of the market. The increasing aging population, high incidence of cancer, and high birth rates in countries, such as the U.K. and France, are driving the growth of the market in the region.
The absorption capacities of the human digestive framework reduce with age, making it difficult for the body to retain all of the needed nutrients from food. Appetite loss is a typical problem among the elderly. As a result, elderly persons do not receive adequate amounts of vitamins. The primary issues among the older population that require nutritional assistance include bone degeneration, poor digestive structure, immobility, and chronic and degenerative disorders. Thus, the senior population is increasingly reliant on nutrition supplements to keep active, which further drives the growth of the enteral nutrition market.
Malnutrition is a serious global concern, and distinct governments and international organizations are making efforts to eradicate the problem. This creates a huge demand for enteral nutrition products in the market.
It is one of the common issues that exist in all countries. According to the World Health Organization, one-third of females of reproductive age are anemic, while 39% of people worldwide are fat or overweight. Furthermore, according to the WHO data, around 20 million newborn kids are born each year who are overweight. According to the 2018 Global Nutrition Report, malnutrition and its related expenses may impose a global burden of nearly $3.5 trillion per year. Thus, government backing, combined with rising incidences of malnutrition worldwide, is projected to drive the market growth in the forecast period.
The study offers a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.
Based on Product Type
Based on Nutrition Type
Based on Form
Based on Patient Type
Based on Distribution Channel
Geographical Analysis
The enteral nutrition market size stood at $8,037.55 million in 2021.
During 2021–2030, the growth rate of the enteral nutrition market will be around 6.2%.
Standard Enteral Nutrition is the largest product type in the enteral nutrition market.
The major drivers of the enteral nutrition market include the growing aged population, rising number of premature births, surging prevalence of chronic conditions, and increasing incidence of malnutrition.
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws